![](/img/cover-not-exists.png)
253PAbemaciclib plus fulvestrant in patients (pts) with HR+/HER2- endocrine therapy naïve (EN) advanced breast cancer - an exploratory analysis of MONARCH 2
Kaufman, P.A., Iwata, H., Nikolinakos, P., Beck, J.T., Koh, H., Gonzalez-Trujillo, J.L., Lin, Y., Barriga, S., Headley, D., Bourayou, N., Llombart Cussac, A., Sledge, G.W.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.016
Date:
September, 2017
File:
PDF, 59 KB
english, 2017